RLYBRallybio Corp

Halper Sadeh LLC, an investor rights law firm, is investigating the merger of Rallybio Corporation (NASDAQ: RLYB) and Avenzo Therapeutics, Inc. Upon closing of the proposed transaction, Rallybio shareholders are expected to own approximately 2.8% of the combined company.Halper Sadeh encourages...

Rallybio announced a merger agreement with Avenzo Therapeutics to create a publicly traded, oncology-focused biotechnology company.

Rallybio Corporation (Nasdaq: RLYB) ("Rallybio") and Avenzo Therapeutics, Inc. ("Avenzo"), a clinical-stage biotechnology company developing next-generation oncology therapies, today announced that they have entered into a definitive agreement pursuant to which Rallybio will acquire Avenzo through...

Rallybio (NASDAQ:RLYB) will be releasing its Q1 2026 earnings before the market opens on Tuesday, May 12. (View Earnings Report at...

Celcuity, Danaher, Vertex Pharmaceuticals, Rallybio, and Moderna are the five Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares of publicly traded companies focused on developing biological products, drugs, diagnostics, or platform technologies...

The market is currently seeing a flurry of activity as companies across the biotech and technology sectors secure substantial funding and execute strategic transformations. $CNSP, $KBLB, $PN, $RLYB, $ADVB, $CLNN, $CABA

Are WSR, TERN, RLYB, DAWN Obtaining Fair Deals for their Shareholders? Are WSR, TERN, RLYB, DAWN Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, April 9, 2026 Insiders may stand to...

Are EWCZ, STEL, RLYB, CTRA Obtaining Fair Deals for their Shareholders? Are EWCZ, STEL, RLYB, CTRA Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, April 6, 2026 Insiders may stand...

Are RLYB, VRME, AES Obtaining Fair Deals for their Shareholders? Are RLYB, VRME, AES Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, March 6, 2026 Insiders may stand to receive...